In a bid to enhance healthcare access across underserved and rural regions, DataMeds AI and Tollo Health have joined forces with the National Football League Alumni Association’s Alumni Health division to introduce the Health Lives Here campaign. This national health initiative is set to connect communities with essential healthcare information, pharmacy services, and health-management tools. By leveraging DataMeds AI’s extensive network of over 6,500 independent pharmacies, the campaign seeks to boost awareness of healthy living and provide consumers with discounted pharmacy services and resources for improved health management.
Central to this initiative is the forthcoming Health Lives Here mobile app, designed as a robust telehealth and health-management platform tailored for consumer use. This application is anticipated to enable users to consolidate their electronic health records while integrating data from wearable devices into a unified health dashboard. Additionally, the platform will offer access to pharmacy-based services and a selection of healthcare products, enhancing the overall healthcare experience for users.
The Health Lives Here initiative was first introduced to former professional football players during the 2026 Football Hall of Fame Game weekend in Canton, Ohio. This strategic introduction sets the stage for a broader public rollout, which is slated to commence in North Carolina in September 2026. As the campaign prepares for its launch, further details regarding the mobile application, participating pharmacies, and other rollout specifics are expected to be revealed.
This partnership merges Tollo Health’s expertise in medical food and nutraceutical products with DataMeds AI’s cutting-edge healthcare technology and pharmacy infrastructure. Meanwhile, the NFL Alumni Association’s health network plays a pivotal role in extending the campaign’s outreach to communities and former professional athletes. The collaboration aims to bridge gaps in healthcare access and promote healthier living among diverse populations.
For those interested in more information or looking to engage with DataMeds AI, media inquiries can be directed to James Lambert, Vice President at Rubenstein Public Relations, via phone at 212-805-3024 or email at [email protected]. Investor-related queries should be sent to Investor Relations at [email protected], with additional resources accessible through their website, https://datamedsai.com/.
Legal Disclaimer: The information contained in this article has been provided by independent third-party contributors, clients, or content partners. We do not independently verify the accuracy, completeness, legality, ownership, licensing, or reliability of submitted content, including text, images, videos, trademarks, or other media materials. The submitting party is solely responsible for ensuring that all content, including images and media assets, complies with applicable copyright, trademark, licensing, and intellectual property laws. We disclaim liability for any unauthorized use of copyrighted or proprietary materials by third parties. If you believe that any content published on this platform infringes your intellectual property rights, kindly contact the author above for prompt review and resolution.